McNair Scholars News


Colon cancer proteins, genes uncover potential treatments

McNair Scholar Dr. Bing Zhang and his team have revealed a more comprehensive view of colon cancer, which may lead to new therapeutic strategies.

Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor growth

McNair Scholar Dr. Xiang Zhang reports a new mechanism that helps cancer cells engage myeloid-derived suppressor for growth.

Subtype of immune B cells can delay diabetes onset in mice

McNair scholar Dr. Massimo Pietropaolo and a team of researchers report that a subset of immune B cells can delay the onset of type 1 diabetes in a mouse model of the condition.

'Listening' to single cells may uncover cancer origins

McNair Scholar Dr. Chenghang Zong worked with a team of scientists to develop a method that allows them to accurately determine the genes expressed in single cells.

New technique tests therapies for breast cancer metastasis

McNair Scholar Dr. Xiang Zhang reports on new laboratory technique that can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone.

New promise found in treating triple negative breast cancer

McNair Scholar Dr. Trey Westbrook reports on a new study that has identified a novel treatment strategy that may be effective for triple negative breast cancer patients.

Making moves to understand cognitive function in the brain

McNair Scholar Dr. Nuo Li and his colleagues have shown in mouse models that parts of the cerebellum are active during short-term memory, even when the body is not in motion, and memory activity in the frontal cortex is dependent on activity in the cerebellum.

Understanding formation of neurons in adult brains

Researchers, including McNair Scholar Dr. Benjamin Arenkiel, have developed a powerful new approach to understand the formation of new neurons in the mammalian adult brain.

DPYSL3 an outlier gene in triple-negative breast cancer

Researchers, including McNair Scholar Dr. Matthew Ellis, have developed an entirely new therapeutic hypothesis on how to treat an aggressive form of triple-negative breast cancer.